McKesson Ventures, LLC 4/A
4/A · Augmedix, Inc. · Filed Sep 20, 2022
Insider Transaction Report
Form 4/AAmended
Augmedix, Inc.AUGX
McKesson Ventures, LLC
Director10% Owner
Transactions
- Purchase
Common Stock
2021-10-28$4.00/sh+112,500$450,000→ 4,047,606 total
Footnotes (1)
- [F1]These securities are held of record by McKesson Ventures LLC ("McKesson"). Jennifer M. Carter, a member of the Issuer's board of directors, is an executive vice president and chief strategy and business development officer at McKesson. As a result, McKesson is a director by deputization for Section 16 purposes.